Dr. Dunlap is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2500 Metrohealth Dr.
The Metrohealth System
Cleveland, OH 44109Phone+1 216-778-5253Fax+1 216-778-3927
Summary
- Mark Dunlap, MD is a member of the HF Program for The MetroHealth System, and is Professor of Medicine, Physiology and Biophysics at Case Western Reserve University in Cleveland, Ohio. He received his MD degree from the University of Tenn. College of Medicine, and completed Internal Medicine, Cardiology, and Research training at the Medical College of Virginia and the VA Medical Center in Richmond, VA. He is a former VA Career Development Awardee and Clinical Investigator. In his current role as Director of the Heart Failure Program for The MetroHealth System he has overseen a dramatic reduction in rehospitalizations for HF.
His basic research has focused on abnormalities of autonomic control in hypertension and heart failure. More recently his work has focused on the role of sympathetic activation causing redistribution of fluid from splanchnic venous vessels into the circulatory volume leading to decompensated HF. His research has been funded by multiple agencies including the NIH, Department of Veterans Affairs, and the American Heart Association. He also has served as investigator, Steering Committee member, and Endpoint Committee member of numerous clinical trials designed to test new therapies in HF, including the NHLBI-sponsored HF Research Network. He is a former member of the Care Standards Committee of the Heart Failure Society of America.
Dr. Dunlap has served on the editorial boards of the Journal of Applied Physiology, American Journal Physiology: Heart & Circulatory Physiology, and the Journal of Cardiac Failure, and regularly serves as abstract reviewer for the American Heart Association and the American College of Cardiology Scientific Sessions. He has also served on numerous study sections for the NHLBI, American Heart Association, and Department of Veterans Affairs, and is past President of the Society for Heart Brain Medicine. He has been recognized for Teaching Excellence and is regularly included among Cleveland Magazine’s “Best Doctors”.
Education & Training
- Baldwin Wallace University MPH, 2017 - 2021
- Virginia Commonwealth University Health SystemFellowship, Cardiovascular Disease, 1985 - 1989
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1982 - 1985
- University of Tennessee Health Science Center College of MedicineClass of 1982
- Oberlin CollegeBA, Math, 1976
Certifications & Licensure
- OH State Medical License 1989 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FAHA) American Heart Association
- Best Doctors Cleveland Magazine, 2011-2019
- Best Research Clinical Paper Frontiers of Cardiology, 2009
- Join now to see all
Clinical Trials
- Telephone Intervention in Heart Failure Patients
- Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Start of enrollment: 2006 Aug 01
- Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure Start of enrollment: 2007 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsGeographic differences in patients in a global acute heart failure clinical trial (from the ASCEND-HF Trial)Marco Metra, Robert J. Mentz, Adrian F. Hernandez, Gretchen M. Heizer, Paul W. Armstrong
The American Journal of Cardiology. 2016-06-01 - 55 citationsChanges in Aortic Stiffness and Augmentation Index After Acute Converting Enzyme or Vasopeptidase InhibitionGary F. Mitchell, Yves Lacourcière, J. Malcolm O. Arnold, Mark E. Dunlap, Paul R. Conlin
Hypertension. 2005-11-01 - 198 citationsEffects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.Michael M. Givertz, Kevin J. Anstrom, Margaret M. Redfield, Anita Deswal, Haissam Haddad
Circulation. 2015-05-19
Journal Articles
- Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensationFallick C, Sobotka PA, Dunlap ME, Circ Heart Fail., 9/1/2011
- Heart Failure Notwithstanding Ejection Fraction (HFnEF)-A Possible Unifying Hypothesis?Dunlap ME, Tang WH, J Card Fail, 1/1/2014
- Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectivenes...Howlett JG, Ezekowitz JA, Podder M, Hernandez AF, Diaz R, Dickstein K, Dunlap ME, Corbalan R, Armstrong PW, Starling RC, O'Connor CM, Califf RM, Fonarow GC; ASCEND-HF ..., Circ Cardiovasc Qual Outcomes, 9/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Rhythm Control with Catheter Ablation Improves Ejection Fraction Compared to Rate Control: A Meta-Analysis of Randomized Controlled Studies.Vallakati A, Reddy AK, Dunlap M, Lewis W, Circulation, 1/1/2014
- Role of Atriove+C431ntricular Junction Ablation in Patients with Atrial Fibrillation Undergoing Cardiac Resynchronization Therapy? - A Meta-Analysis.Vallakati A, Sengodan P, Dunlap M, Journal of Cardiac Failure, 1/1/2014
- Hospital Management of Hyponatremia in Patients with Heart Failure: Final Report from the HN Registry.Chiong JR, Hauptman PJ, Dunlap ME, Chiodo JA, Chase SL, Journal of Cardiac Failure, 1/1/2014
- Join now to see all
Lectures
- “Strategies for Reducing HF readmissions”The MetroHealth System, Cleveland, OH - 11/1/2014
- “Matthew N. Levy: The Gentleman Researcher and Hunter of the Wild Vagus”Cleveland, OH - 10/1/2014
- “Updates in Cardiology: exercise and implanted hemodynamic monitoring in HF”MetroHealth Medical Center, Cleveland, OH - 9/1/2014
- Join now to see all
Other
- “Heart Failure and the INOVATE-HF Clinical Trial"Dunlap M, "Golden Opportunities", Channel 3 TV
Cleveland, OH - 2/1/2013 - “HypertensionWRAP: Focus on Approach to Heart Failure”Dunlap M, Webcast CME program
http://healthwraps.com/emailthis/default.aspx?id=256
12/1/2006 - Invited guest, WZAK radio talk show, “Heart Disease in African Americans”Dunlap M
12/1/2006 - Join now to see all
Grant Support
- PRE And Postganglionic Vagal Mechanisms In Heart FailureNational Heart, Lung, And Blood Institute1995–1997
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: